Low Prevalence of SARS-CoV-2 Among Pregnant and Postpartum Patients With Universal Screening in Seattle, Washington

Clin Infect Dis. 2020 May 30;ciaa675. doi: 10.1093/cid/ciaa675. Online ahead of print.

Abstract

We found a low prevalence of SARS-CoV-2 (2.7% [5/188]) among pregnant and postpartum patients after initiating universal testing. Prevalence among symptomatic patients (22.2% [4/18]) was similar to initial targeted screening approaches (19.1% [8/42]). Among 170 asymptomatic patients, two were positive or inconclusive, respectively; repeat testing at 24 hours was negative.

Keywords: COVID-19; SARS-CoV-2; pregnancy; universal screening; viral shedding.